argenx SE | ARGX - Ebit





Ebit Veränderung Datum
AstraZeneca USD 4.66B 1.5B 2026-09
Genmab DKK 407M 221M 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
GRIFOLS EUR 394M 34M 2026-09
Hikma Pharmaceutical USD 348M 31M 2025-12
Lakefront Biotherapeutics EUR -43.51M 20.19M 2026-06
Qiagen NV USD 141.4M 44.52M 2026-06
UCB EUR 1.29B 571M 2025-12